We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Our individual responses to diet are governed, in part, by our unique microbiome
- The microbiome influences responses to diet
- Translating microbiome composition into ecosystem function
- Over the last century, we have gained extensive knowledge of biochemistry and metabolism
- What’s the best measure of metabolic function?
- Community-scale metabolic modeling for precision microbiome-mediated medicine
- Flux Balance Analysis (FBA)
- MIcrobial COMmunity (MICOM )
- More is different: cooperative tradeoff Flux Balance Analysis (ctFBA)
- MICOM enables exploration of taxon-taxon interactions in complex communities
- Translational potential: Clostridioides difficile
- Validation: in vitro engraftment prediction
- Validation: in vivo engraftment prediction
- Metabolic plasticity across environmental contexts
- Towards precision probiotic cocktail design to prevent or reverse C. difficile colonization
- Translational potential: short chain fatty acid
- Butyrate: A key cardiometabolic molecule you might not know about
- Model validation: poop soup experiments
- Predicting personalized SCFA (butyrate and propionate) production in humans
- Blood-based clinical chemistries associated with butyrate predictions in the human cohort
- Using MICOM to simulate personalized effects of diet shifts and pre/probiotic co-interventions
- Co-intervention outcomes among high-fiber diet non-responders and regressors
- How to improve MCMMs predictive capacity to move towards translational applications?
- Data-driven dietary intake assessments
- Metagenomic estimation of dietary intake (MEDI)
- MEDI controls for false positives and false negatives
- Phylogenetically related organisms have similar nutrient contents
- Estimating dietary intake directly from metagenomic data in infants
- Estimating dietary intake directly from metagenomic data in adults
- Validating food intake predictions in controlled feeding study
- Validating nutrient intake predictions in controlled feeding study - micronutrients
- Estimating dietary intake directly from meta-genomic data that lack questionnaire data
- Converting dietary intake into nutritional intake METACARDIS
- MEDI-inferred nutritional intake could be leveraged to improve MICOM predictions
- Thank you and acknowledgements
- Financial disclosures
Topics Covered
- Computational modeling
- Gut-microbiome interaction
- Microbiome and nutrition metabolism
- Diet and metabolic disorders
- Personalized medicine
- Dietary tests
- Dietary assessment
Links
Series:
Categories:
External Links
Talk Citation
Gibbons, S. (2025, December 31). Microbial community-scale metabolic modeling and precision nutrition [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved January 10, 2026, from https://doi.org/10.69645/HDXY1129.Export Citation (RIS)
Publication History
- Published on December 31, 2025
Financial Disclosures
- Dr. Sean Gibbons is a paid member of the Thorne scientific advisory board. Thorne was not involved in any of the work presented in this talk.
Transcript
Please wait while the transcript is being prepared...
0:00
Hello, everyone. I
am Sean Gibbons,
an associate professor at
the Institute for Systems
Biology in Seattle,
and today, I'm going to talk
about some of our recent work
in microbial community-scale
metabolic modeling
and precision nutrition.
0:17
As background to this work,
I'll talk a little bit
about the human microbiome.
You may or may not know that
we are mostly microbial,
that a slight majority of
the cells in our
bodies are microbial.
But we're about 50%;
we're about on par.
However, the genetic
capacity of our bodies is
vastly weighted
towards the microbes.
There are something 4-6
million unique genes
in the microbiome, and
only about 23000 genes
in the human genome.
So there's a huge amount
of genetic capacity
pent up in this ecosystem of
organisms that inhabit our bodies,
bacteria, archaea,
fungi, and viruses.
It's part of what
makes us unique.
It's part of how we respond to
environmental stimuli
to diet, to drugs.
Some of that variation
in how we respond,
yes, is due, in
part, to our genome,
but also to the activity
of our microbiota.
For example, identical twins,
who share the exact same genome,
have completely
distinct microbiomes
even as distinct as two
strangers, practically.
For all of us, this is the part
of our bodies that makes us
unique and drives unique
responses to the environment.
1:28
We've known for many years that
the microbiome affects
our phenotypic responses.
There's a classic paper,
Turnbaugh et al.
from back in 2006,
where they essentially
took feces from
lean individuals and
overweight individuals,
and they transplanted these
feces into germ-free mice,
different sets of
these germ-free mice.
So some got the lean microbiota.
Some got the obese microbiota.
And they fed these mice
the exact same diet,
and the mice that had
the transplant from
the obese individuals
gained more weight,
and you can see the
picture of the two mice
here on the right-hand side.
It's been difficult to translate
this knowledge into therapeutics
because we haven't quite
known mechanistically
what's going on.
We know that there's an effect,
but how and why this effect
is happening is less clear.